How Carequality navigates a conflict between Epic and Particle Health carries big implications for the future of health data ...

After demonstrating safety, the brain-computer interface field is now poised to leap from the lab to the real world.

Opinion: Louisiana’s new restrictions on mifepristone and misoprostol threaten to negate the state’s recent gains in maternal ...

Opinion: Universities can achieve their societal mission to advance knowledge and debate while protecting all voices through ...

U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird ...

Earlier this year, STAT’s Eric Boodman reported the heartbreaking story of how, for decades, doctors have pressured sickle ...

A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients ...

Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.

The leading CPAP device maker's CEO sees 'two tidal waves' of innovation driving more people to the company's devices.

A major California health insurer is set to offer one of the world’s top-selling drugs for free in a bid to show it can reach ...

The connectome could help researchers better understand how to treat diseases like Alzheimer's and Parkinson's.

Eli Lilly will invest $4.5 billion to create the Lilly Medicine Foundry, which the drug giant says will be the first-ever ...